Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer. [electronic resource]
Producer: 20100504Description: 541-5 p. digitalISSN:- 1791-7530
- Adenocarcinoma -- drug therapy
- Adenocarcinoma, Papillary -- drug therapy
- Adult
- Cisplatin -- therapeutic use
- Cystadenocarcinoma, Serous -- drug therapy
- Endometrial Neoplasms -- drug therapy
- Female
- Humans
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Prognosis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.